Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Series TitleSeries Title
-
Reading LevelReading Level
-
YearFrom:-To:
-
More FiltersMore FiltersContent TypeItem TypeIs Full-Text AvailableSubjectCountry Of PublicationPublisherSourceTarget AudienceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
878,954
result(s) for
"Surveillance"
Sort by:
Surveillance : a very short introduction
by
Lyon, David, 1948- author
in
Police patrol Surveillance operations.
,
Electronic surveillance.
,
True Crime.
2024
Examines the key processors of and concepts surrounding surveillance. It explains that surveillance is central to doing business, meeting friends, organizing governance, maintaining security, and being entertained. Surveillance makes people visible to organizations.
Expanding the gaze : gender and the politics of surveillance
\"From sexualized selfies and hidden camera documentaries to the bouncers monitoring patrons at Australian nightclubs, the ubiquity of contemporary surveillance goes far beyond the National Security Agency's bulk data collection or the proliferation of security cameras on every corner. Expanding the Gaze is a collection of important new empirical and theoretical works that demonstrate the significance of the gendered dynamics of surveillance. Bringing together contributors from criminology, sociology, communication studies, and women's studies, the eleven essays in the volume suggest that we cannot properly understand the implications of the rapid expansion of surveillance practices today without paying close attention to its gendered nature. Together, they constitute a timely interdisciplinary contribution to the development of feminist surveillance studies.\"-- Provided by publisher.
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2024
2025
Exposure incidents to human pathogens and toxins (HPTs) in licensed facilities in Canada are monitored by Laboratory Incident Notification Canada (LINC), a surveillance system that describes and identifies trends among exposure incidents in Canada using quantitative and qualitative data.
Confirmed exposure incidents reported to LINC in 2024 were analyzed. The exposure incident rate was calculated and compared to previous years. A seasonality analysis compared monthly trends. Exposure incidents were described by sector, implicated HPTs, main activity, occurrence types, root causes, affected individuals and reporting delay. Text-based descriptions of exposure incidents underwent qualitative analysis.
In 2024, there were 71 confirmed exposure incidents affecting 132 individuals. There were 67.5 incidents per 1,000 active licences. Bacteria was the most commonly implicated HPT (64%). Microbiology (67.6%) was the primary activity during confirmed exposures. The public health sector had the highest incident rate and mean number of affected persons per active licence. The most frequently reported occurrence type and root cause was procedure-related (21.4%) and human factors (62%), respectively. Most affected individuals were technicians/technologists (76.5%). The median time between incident and reporting was five days.
The exposure incident rate was higher in 2024 compared to the previous year. The public health sector had the highest incident rate between 2016-2024. Qualitative analysis revealed that working with cultures outside the biological safety cabinet and insufficient face-related personal protective equipment were common factors involved in confirmed exposure incidents.
Journal Article
Space electronic reconnaissance : localization therories and methods
\"Presents the theories and applications of determining the position of an object in space through the use of satellites\"-- Provided by publisher.
Evaluation of a real-time hospital surveillance system for respiratory syncytial virus, Ontario, Canada, 2022–2023
2025
Respiratory syncytial virus (RSV) surged in the 2022-2023 respiratory season after low activity during the pandemic. To monitor the RSV season in real time and support healthcare planning, Ontario introduced daily hospital bed census reporting of RSV hospitalizations by age group (0-17, 18-64, 65 years and older).
To assess the completeness and quality of the newly introduced real-time surveillance compared to end-of-season ICD-10 coded hospitalization discharge abstract data (DAD) from November 22, 2022, to March 31, 2023.
Respiratory syncytial virus hospitalizations from both data sources were compared to RSV laboratory positivity to assess concordance with overall RSV activity. A longitudinal comparison by age group was assessed by time-lagged cross-correlation of the daily submission data versus DAD data, including cross correlation coefficients for each time lag, confidence bound and the highest correlation value.
Both data sources followed trends in RSV positivity. Data by age groups showed an early peak of paediatric admissions followed by a peak in adult and older adult hospitalizations. Daily surveillance consistently underestimated hospitalizations with a peak of 430 beds by DAD on January 7, 2023, versus 322 beds (75%) for daily reporting on the same day. The maximum correlation coefficient values were 0.67 (all ages), 0.57 (0-17 years), 0.66 (18-64 years) and 0.63 (65 years and older).
Implementation of daily hospital reporting provided accurate trending in RSV hospitalizations by age group to inform within season healthcare and public health planning.
Journal Article
Disease surveillance : technological contributions to global health security
by
Blazes, David L., editor
,
Lewis, Sheri H., MPH, editor
in
Public health surveillance Technological innovations.
,
Public health surveillance Data processing.
,
Public Health Surveillance methods.
2016
Providing an overview of disease surveillance, this text frames a roadmap of how newer technologies may allow all countries of the world to reach compliance with the IHR (International Health Regulations) established by the World Health Organization as it pertains to disease detection.
214 12-Month Post Marketing Safety Surveillance Data of Chewable Inulin Fiber
2019
INTRODUCTION:Most Americans consume only half of the daily fiber recommended by the National Academy of Medicine, which is 25 grams per day of fiber for women and 38 grams per day for men. Fiber has been shown to promote bowel regularity, lower cholesterol, control blood sugar, and maintain body weight. To fill the “fiber gap” many patients use fiber supplements. There is a perception that fiber supplementation can lead to bloating and excess gas production, among other adverse events. This study aimed to examine whether or not a pattern of adverse events was associated with chewable inulin fiber (CIF).METHODS:A call-in number for reporting adverse events (AEs) was provided on bottles of a specific brand of CIF. An independent call center with pharmacovigilance-trained health care personnel in accordance with the FDA and global regulatory guidelines on properly reporting AEs was retained to receive and record customer AEs. The AEs for this study were collected and processed from January 1, 2018 to December 31, 2018.RESULTS:An estimated 809,259 individual patients consumed CIF during the surveillance. An analysis of the data showed that there were no serious AEs reported. Additionally, the self-reporting rate of non-serious AEs was low, with only 23 non-serious events reported by 21 individuals; a rate of 2.8 per 100,000 users. The top reported, non-serious AEs were flatulence, diarrhea, and constipation; however, the rates for these were extremely low (4.9, 3.7, and 1.2 per million, respectively). Two events were reported that were classified as musculoskeletal and connective tissue disorders; however, these were considered to not be related, having no basis for biological plausibility.CONCLUSION:12 months of monitoring real-world use of CIF in a population of over 800,000 patients demonstrates an extremely low rate of self-reported AEs. Contrary to conventional thinking, the rate of flatulence was remarkably low (4.9 per million users), and can most likely be considered statistical background noise. These data, combined with previous RCTs, indicates that CIF is a safe and effective option for fiber supplementation.Table 1.Most common reported related adverse events.
Journal Article